{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
SOTI HAIR GROWTH SERUM by Guangzhou Jianyuan Biological Technology Co., Ltd.
(2023)
Source URL:
First approved in 2023
Source:
SOTI HAIR GROWTH SERUM by Guangzhou Jianyuan Biological Technology Co., Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Toothy Oral Solution by Shenzhen Roselle Bio-Technology Holding Co.,Ltd.
(2020)
Source URL:
First approved in 2020
Source:
Toothy Oral Solution by Shenzhen Roselle Bio-Technology Holding Co.,Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 352
(2017)
Source URL:
First approved in 2016
Source:
M020
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2015)
Source URL:
First approved in 2014
Source:
Therapytion Nokmosu Hair Tonic by Therapytion Co., Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
TAMNAMO PLUS VITAL HAIR by Tamnamo Co., Ltd
(2013)
Source URL:
First approved in 2013
Source:
TAMNAMO PLUS VITAL HAIR by Tamnamo Co., Ltd
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
First approved in 2012
Source:
JEUNCELL a drug for atopic dermatitis by Jeun Cell Ltd
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 346
(2004)
Source URL:
First approved in 2004
Source:
21 CFR 346
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2001)
Source URL:
First approved in 2001
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2024)
Source URL:
First approved in 2000
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE